In contrast, IGF-1 bound to IGFBP-1 does not form complexes with ALS, is able to cross the endothelial barrier and is, consequently, more likely to play a role in the regulation of IGF-1 bioactivity at extravascular tissues (Lee et al, 1993). Here, IGF1 is linked to amyotrophic lateral sclerosis.